4//SEC Filing
Taylor Andrew Lawrence 4
Accession 0001104659-24-059991
CIK 0001814114other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:18 PM ET
Size
5.5 KB
Accession
0001104659-24-059991
Insider Transaction Report
Form 4
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2024-05-08+100,000→ 378,363 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 15,000 RSUs will vest on May 20, 2025, and (ii) the remaining 85,000 RSUs will vest in equal installments on August 20, 2025, November 20, 2025, December 20, 2025, May 20, 2026, August 20, 2026, November 20, 2026, March 25, 2027, May 20, 2027, August 20, 2027, November 20, 2027, March 25, 2028 and May 20, 2028, subject to the Reporting Person's continuous service through such dates.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001723889
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:18 PM ET
- Size
- 5.5 KB